• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LU Yayuan,ZHAO Di,LI Ning,LU Shan,CHEN Xijing.Research advances of controlled release formulations for pulmonary delivery[J].Journal Of Pharmaceutical Research,2018,37(8):469-472,481[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3542times   Download 3300次 QR Code for this article
Scan with your phone!
缓释型肺吸入制剂的研究进展
陆亚媛1,赵娣1,李宁1,卢山2,陈西敬1
Font:Larger+|Default|Smaller-
(1.中国药科大学基础医学与临床药学学院临床药物代谢动力学研究室,江苏 南京 211198;2.湖北中医药大学药学学院,湖北 武汉 430065)
摘要:
近年来,肺吸入制剂因为直接将药物递送至患病部位、无首过效应、患者依从性大等优点,成为研究热点。但肺吸入制剂仍然存在许多问题如药物消除迅速、给药次数频繁、存在临床用药安全性隐患。本文将从肺部主要的消除机制入手,对目前缓释肺吸入制剂进行综述,为今后肺吸入的临床应用提供思路。
关键词:  药物传递系统  肺吸入给药  药物消除机制  缓释制剂
DOI:10.13506/j.cnki.jpr.2018.08.010
基金项目:国家自然科学基金项目(No.81473272、81503148)
Research advances of controlled release formulations for pulmonary delivery
LU Yayuan1,ZHAO Di1,LI Ning1,LU Shan2,CHEN Xijing1
(1.Clinical Pharmacokinetics Laboratory,School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 211198,China;2.College of Pharmacy,Hubei University of Chinese Medicine,Wuhan 430065,China)
Abstract:
In recent years,the targeted pulmonary delivery has received increasing attention,with the merit of direct drug deposition at the diseased site,lack of first pass metabolism and good compliance of patients.However,it is strictly challenged in many different ways such as the efficient clearance mechanisms,frequent dosing and clinical medication safety problem.This review covered these controlled release formulations for the clinical application of pulmonary delivery, based on lung clearance mechanisms.
Key words:  Drug delivery system  Pulmonary drug delivery  Clearance mechanisms  Controlled release formulations
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.